Home › Compare › LSIIF vs ABBV
LSIIF yields 0.77% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, LSIIF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LSIIF + ABBV for your $10,000?
Lisi S.A. provides assembly and component solutions for the aerospace, automotive, and medical industries in France and internationally. It operates through three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. It offers titanium nuts, lightning strike protection, safety locks, and fuse pins; compressor blade and strut for the LEAP engine; LEAP engines composite fan blade leading edge; air intake lipskin for the airbus; power transmission semi-machined gears; stator vanes; and satellite antenna brackets for airplanes and helicopters. It also provides guide pins and electric parking brakes; braking systems and direct engine injections; screws and nuts; belt and seat mechanism products; special parts for motors and safety systems; clips for interior and exterior trim; assembly reduction and optimization solutions; and cable ducts. In addition, it offers assembly solutions, battery fastening systems, complex power transmission parts, and other automotive standard fasteners; clipped fastening systems for interior and exterior cladding, fasteners for tubes and cables, as well as solutions for weight reduction and optimizing assemblies; and covers components for braking, fluid management, and seat adjustment and interior safety systems. Further, it engages in the designing and modeling, prototypes, pre-series, materials, process validation, and replenishment of inventories; offers shoulders, reconstruction implants solutions for hips, knees, extremities, and instruments; blades, scissors, staplers, and pliers for surgery; and spinal and trauma implants, such as connectors, screws, cages, plates, and prostheses medical devices for treating trauma and osteosynthesis. The company was formerly known as GFI Industries and changed its name to LISI S.A. in 2002. The company was founded in 1777 and is headquartered in Belfort, France. Lisi S.A. operates as a subsidiary of Compagnie Industrielle De Delle S.A.
Full LSIIF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.